Title of article :
Review of Ocular Manifestations and Drugs Used for the Treatment of Ocular Complaints in COVID-19
Author/Authors :
Khorram ، Arash Department of Microbiology - School of Medicine - Alborz University of Medical Sciences , Khosravi-Dehaghi ، Nafiseh Department of Pharmacognosy - School of Pharmacy, Evidence-Based Phytotherapy and Complementary Medicine Research Center - Alborz University of Medical Sciences , Hajikhani ، Bahareh Department of Microbiology - School of Medicine - Shahid Beheshti University of Medical Sciences , Dadashi ، Masoud Department of Microbiology - School of Medicine, Non-Communicable Diseases Research Center - Alborz University of Medical Sciences , Sameni ، Fatemeh Department of Microbiology - Faculty of Medicine, Molecular Microbiology Research Center - Shahed University
Abstract :
SARS-CoV-2 has been infrequently isolated from conjunctival swabs; it is associated with ocular manifestations, including conjunctivitis, blurred vision, dry eye, and hyperemia in patients with confirmed COVID-19. In some cases, ocular manifestations may be the first and only symptoms of COVID-19 related to the greater severity of the systemic disease. According to the eye manifestations, physicians have prescribed different medications. For example, drugs such as azithromycin eye drops, dexamethasone, moxifloxacin, and ganciclovir ophthalmic gel have been used for the treatment of conjunctivitis. The role of ophthalmologists in the prevention and screening of COVID-19 is highlighted due to the ocular manifestations. The most common ocular symptoms associated with COVID-19 infection, treatment, and potential side effects of drugs utilized to combat these complications are reviewed in this article.
Keywords :
COVID , 19 , Ophthalmology , Ocular manifestations , Conjunctivitis , Treatment , Side , effects
Journal title :
International Journal of Enteric Pathogens
Journal title :
International Journal of Enteric Pathogens
